Internal Medicine, Hematology & Oncology · Chicago, IL
NPI
1861657785
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
5841 S Maryland Ave
Chicago, IL, 60637
Phone (888) 824-0200
Groups this clinician bills Medicare through
Medicare paid, 2024
$153K
2,321 services
Medicare patients, 2024
399
Average age 76
Drug cost, 2024
$3.0M
1,687 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tabraiz A Mohammed was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 676 times for 211 patients. In total Tabraiz A Mohammed billed 2,321 services in 16 codes, and Medicare paid $153K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-24.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 676 | 211 | $14.56 | $9,845 |
| 99214 Office E&M - Established | Office | 659 | 220 | $80.93 | $53K |
| 99232 Hospital E&M - Subsequent | Facility | 253 | 93 | $69.00 | $17K |
| 99215 Office E&M - Established | Office | 183 | 91 | $122.88 | $22K |
| 99213 Office E&M - Established | Office | 170 | 109 | $55.24 | $9,392 |
| 99233 Hospital E&M - Subsequent | Facility | 111 | 42 | $103.72 | $12K |
| 99222 Hospital E&M - Initial | Facility | 74 | 67 | $115.03 | $8,512 |
| 99231 Hospital E&M - Subsequent | Facility | 43 | 34 | $43.57 | $1,873 |
| 99205 Office E&M - New | Office | 42 | 42 | $151.66 | $6,370 |
| 99223 Hospital E&M - Initial | Facility | 40 | 34 | $151.40 | $6,056 |
| 99204 Office E&M - New | Office | 28 | 28 | $114.25 | $3,199 |
| 99221 Hospital E&M - Initial | Facility | 24 | 20 | $70.11 | $1,683 |
By year: 2022 $142K for 1,739 services; 2023 $131K for 1,536 services; 2024 $153K for 2,321 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tabraiz A Mohammed prescribed most often to Medicare patients was Anastrozole, with 156 prescriptions and refills. In total Tabraiz A Mohammed wrote 1,687 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 156 | 351 | 41 | $2,610 |
| Eliquis Apixaban | 128 | 170 | 28 | $91K |
| Prochlorperazine Maleate Generic | 100 | 100 | 66 | $733 |
| Acyclovir Generic | 98 | 134 | 21 | $1,053 |
| Ondansetron Hcl Generic | 87 | 87 | 59 | $628 |
| Gabapentin Generic | 75 | 84 | 20 | $866 |
| Pantoprazole Sodium Generic | 61 | 116 | 27 | $706 |
| Potassium Chloride Generic | 55 | 95 | 24 | $570 |
| Prednisone Generic | 46 | 52 | 21 | $210 |
| Revlimid Lenalidomide | 46 | 46 | Under 11 | $842K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 40 | 40 | 19 | $881 |
| Dexamethasone Generic | 34 | 36 | 21 | $801 |
| Warfarin Sodium Generic | 28 | 56 | Under 11 | $266 |
| Tramadol Hcl Generic | 27 | 27 | 12 | $139 |
| Alunbrig Brigatinib | 25 | 25 | Under 11 | $377K |
Brand drugs: - claims; generic drugs: 1,304 claims; opioid claims: 114.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Tabraiz A Mohammed were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.